The high degree of specificity of the construct was precisely designed to prevent activation in non-malignant cells to avoid normal cell toxicity at the expense of losing an anti-tumor effect in malignant cells with either wt Ras and/or wt p53 genotypes. Here, TP53 is linked to neoplasm.